Experienced in Choledocholithiasis

Masayoshi Kobayashi

Department Of Otorhinolaryngology Head And Neck Surgery, 
Tsu, JP 
Experienced in Choledocholithiasis
Department Of Otorhinolaryngology Head And Neck Surgery, 
Tsu, JP 
OverviewLocationsClinical Research

Overview

Masayoshi Kobayashi practices in Tsu, Japan. Mr. Kobayashi is rated as an Experienced expert by MediFind in the treatment of Choledocholithiasis. His top areas of expertise are Anosmia, Cerebral Hypoxia, Choanal Atresia, Lithotripsy, and Endoscopy.

His clinical research consists of co-authoring 113 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Choledocholithiasis.

Gender
Male

Locations

Department Of Otorhinolaryngology Head And Neck Surgery, Tsu, Japan
Other Locations
Department Of Otorhinolaryngology Head And Neck Surgery, Miemachi, Japan
Sumida, 1308575, Japan
Tokyo, Japan
Chiba, Japan
Sumida, Japan
Tokoname, Japan
Kyoto, 6128486, Japan
Toyoake, Japan
Chuo, 2608670, Japan
Nishinomiya-hama, Japan
Japan
R&D Department 1, 322 Furukawa Cho, Hazukashi, Fushimi, 6128486, Japan
Kamogawa, Japan
Okazaki, Japan
Shinshu, Japan
Kameda, 2960041, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
A Randomised, Double-blind, Placebo Controlled, Parallel Group Phase III Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) / Eosinophilic Chronic Rhinosinusitis (ECRS) MERIT: Mepolizumab in Eosinophilic Chronic RhinosinusITis Study
Enrollment Status: Completed
Publish Date: November 25, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Standard of Care
Study Phase: Phase 3

113 Total Publications

Elezanumab Accelerates Post-Injury Regeneration of Olfactory Sensory Neurons in a Methimazole-Induced Mouse Model.
Elezanumab Accelerates Post-Injury Regeneration of Olfactory Sensory Neurons in a Methimazole-Induced Mouse Model.
Journal: International forum of allergy & rhinology
Published: March 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kobayashi's expertise for a condition
ConditionClose
      View All 44 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile